FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1998866410> ?p ?o ?g. }

• W1998866410 endingPage "469" @default.
• W1998866410 startingPage "464" @default.
• W1998866410 abstract "We found previously that mice injected intracerebrally (i.c.) with a mixture of malignant cells and allogeneic fibroblasts genetically engineered to secrete interleukin-2 (IL-2) survived longer than mice in various control groups. The primary goal of this study was to determine if an established i.c. glioma (Gl261) or breast carcinoma (SB-5b) could be treated by injection of IL-2-secreting allogeneic fibroblasts into the tumor region. As an additional objective, these results were compared with the effectiveness of injecting IL-2-secreting allogeneic fibroblasts prior to the introduction of the tumor cells as a means of preventing the development of an i.c. glioma or breast carcinoma. The results demonstrated that treatment of mice bearing an established i.c. glioma or breast carcinoma with IL-2-secreting allogeneic fibroblasts resulted in a prolonged survival. Furthermore, the results demonstrate a significant delay (P<.005) in the development of glioma in the animals treated with either allogeneic nonsecreting or IL-2-secreting fibroblasts prior to introduction of tumor cells. In addition, 50% of the animals pretreated with IL-2-secreting allogeneic fibroblasts injected subsequently with Gl261 glioma cells did not develop a tumor, whereas all of the animals injected with glioma cells alone and 92% of those treated with nonsecreting fibroblasts eventually died. Evidence also exists that long-term immunity was established in the treated animals because there was a significant prolongation of survival in comparison to naïve controls (P<.01) for those animals without evidence of glioma that previously had been immunized with treatment cells when challenged again with tumor cells. In a parallel experiment, 62% of the animals pretreated with nonsecreting allogeneic fibroblasts and 75% of the animals pretreated with allogeneic IL-2-secreting fibroblasts subsequently injected with SB-5b breast carcinoma cells did not develop tumors. The results indicate that IL-2-secreting allogeneic fibroblasts can be effective in the treatment of an established brain tumor. These data also suggest that i.c. injection of allogeneic IL-2-secreting fibroblasts is effective in prevention of the development of a brain tumor when the fibroblasts are introduced into the same site where the tumor is subsequently injected." @default.
• W1998866410 created "2016-06-24" @default.
• W1998866410 creator A5030794898 @default.
• W1998866410 creator A5044315589 @default.
• W1998866410 creator A5075950979 @default.
• W1998866410 creator A5081153366 @default.
• W1998866410 creator A5082212705 @default.
• W1998866410 creator A5085654587 @default.
• W1998866410 date "2002-04-22" @default.
• W1998866410 modified "2023-10-06" @default.
• W1998866410 title "Application of interleukin-2–secreting syngeneic/allogeneic fibroblasts in the treatment of primary and metastatic brain tumors" @default.
• W1998866410 cites W1570512026 @default.
• W1998866410 cites W1705182747 @default.
• W1998866410 cites W1977404595 @default.
• W1998866410 cites W1992717099 @default.
• W1998866410 cites W2027388483 @default.
• W1998866410 cites W2047152719 @default.
• W1998866410 cites W2049822454 @default.
• W1998866410 cites W2056618475 @default.
• W1998866410 cites W2091146108 @default.
• W1998866410 cites W2108117103 @default.
• W1998866410 cites W2119771497 @default.
• W1998866410 cites W2143001129 @default.
• W1998866410 cites W2163249554 @default.
• W1998866410 cites W30300769 @default.
• W1998866410 cites W4247590927 @default.
• W1998866410 doi "https://doi.org/10.1038/sj.cgt.7700459" @default.
• W1998866410 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11961669" @default.
• W1998866410 hasPublicationYear "2002" @default.
• W1998866410 type Work @default.
• W1998866410 sameAs 1998866410 @default.
• W1998866410 citedByCount "39" @default.
• W1998866410 countsByYear W19988664102012 @default.
• W1998866410 countsByYear W19988664102020 @default.
• W1998866410 countsByYear W19988664102022 @default.
• W1998866410 crossrefType "journal-article" @default.
• W1998866410 hasAuthorship W1998866410A5030794898 @default.
• W1998866410 hasAuthorship W1998866410A5044315589 @default.
• W1998866410 hasAuthorship W1998866410A5075950979 @default.
• W1998866410 hasAuthorship W1998866410A5081153366 @default.
• W1998866410 hasAuthorship W1998866410A5082212705 @default.
• W1998866410 hasAuthorship W1998866410A5085654587 @default.
• W1998866410 hasBestOaLocation W19988664101 @default.
• W1998866410 hasConcept C142724271 @default.
• W1998866410 hasConcept C203014093 @default.
• W1998866410 hasConcept C2777546739 @default.
• W1998866410 hasConcept C2778227246 @default.
• W1998866410 hasConcept C502942594 @default.
• W1998866410 hasConcept C71924100 @default.
• W1998866410 hasConceptScore W1998866410C142724271 @default.
• W1998866410 hasConceptScore W1998866410C203014093 @default.
• W1998866410 hasConceptScore W1998866410C2777546739 @default.
• W1998866410 hasConceptScore W1998866410C2778227246 @default.
• W1998866410 hasConceptScore W1998866410C502942594 @default.
• W1998866410 hasConceptScore W1998866410C71924100 @default.
• W1998866410 hasIssue "5" @default.
• W1998866410 hasLocation W19988664101 @default.
• W1998866410 hasLocation W19988664102 @default.
• W1998866410 hasOpenAccess W1998866410 @default.
• W1998866410 hasPrimaryLocation W19988664101 @default.
• W1998866410 hasRelatedWork W1104561468 @default.
• W1998866410 hasRelatedWork W1982384564 @default.
• W1998866410 hasRelatedWork W2380995253 @default.
• W1998866410 hasRelatedWork W2508252533 @default.
• W1998866410 hasRelatedWork W2618376745 @default.
• W1998866410 hasRelatedWork W2732784745 @default.
• W1998866410 hasRelatedWork W3208778134 @default.
• W1998866410 hasRelatedWork W4245617172 @default.
• W1998866410 hasRelatedWork W4280653383 @default.
• W1998866410 hasRelatedWork W3005931108 @default.
• W1998866410 hasVolume "9" @default.
• W1998866410 isParatext "false" @default.
• W1998866410 isRetracted "false" @default.
• W1998866410 magId "1998866410" @default.
• W1998866410 workType "article" @default.